| 2024-12-05 |
详情>>
业绩披露：
2025年一季报每股收益0.08美元,归母净利润1116.40万美元,同比去年增长-28.15%
|
| 2024-12-02 |
股东大会：
将于2024-12-23召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated October 6, 2024 (the “Merger Agreement”), by and among Duckhorn, Marlee Buyer, Inc. (“Parent”), and Marlee Merger Sub, Inc., a wholly owned subsidiary of Parent (“Merger Sub”). Upon the terms and subject to the conditions of the Merger Agreement, Merger Sub will merge with and into Duckhorn, with Duckhorn continuing as the surviving corporation (the “Surviving Corporation”) and a wholly owned subsidiary of Parent (the “Merger”);
2.To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Duckhorn’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the “Compensation Proposal”);
3.To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2024-12-02 |
详情>>
股本变动：
变动后总股本14720.06万股
|
| 2024-10-09 |
详情>>
内部人交易：
Przybylinski Pete等共交易4笔
|
| 2024-10-07 |
详情>>
业绩披露：
2024年年报每股收益0.45美元,归母净利润5601.30万美元,同比去年增长-19.17%
|
| 2024-10-07 |
详情>>
业绩披露：
2022年年报每股收益0.52美元,归母净利润6019.00万美元,同比去年增长7.53%
|
| 2024-10-07 |
财报披露：
美东时间 2024-10-07 盘后发布财报
|
| 2024-06-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.39美元,归母净利润4471.70万美元,同比去年增长-13.22%
|
| 2024-03-07 |
详情>>
业绩披露：
2024年中报每股收益0.27美元,归母净利润3139.40万美元,同比去年增长-9.61%
|
| 2023-12-06 |
详情>>
业绩披露：
2024年一季报每股收益0.13美元,归母净利润1553.70万美元,同比去年增长-21.59%
|
| 2023-11-22 |
股东大会：
将于2024-01-19召开股东大会
会议内容 ▼▲
- 1.Election of the two director nominees named in the Proxy Statement to serve until the annual meeting of stockholders occurring in the fiscal year ending July 31, 2027 (“Fiscal 2027”);
2.Ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for the fiscal year ending July 31, 2024 (“Fiscal 2024”);
3.Approval, on an advisory basis, of the compensation of our named executive officers;
4.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2023-09-27 |
详情>>
业绩披露：
2021年年报每股收益0.52美元,归母净利润5597.60万美元,同比去年增长72.89%
|
| 2023-09-27 |
详情>>
业绩披露：
2023年年报每股收益0.60美元,归母净利润6929.80万美元,同比去年增长15.13%
|
| 2023-06-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.45美元,归母净利润5152.90万美元,同比去年增长-5.92%
|
| 2023-03-08 |
详情>>
业绩披露：
2023年中报每股收益0.30美元,归母净利润3473.20万美元,同比去年增长-11.41%
|
| 2022-12-07 |
详情>>
业绩披露：
2023年一季报每股收益0.17美元,归母净利润1981.50万美元,同比去年增长-6.85%
|
| 2022-11-23 |
股东大会：
将于2023-01-20召开股东大会
会议内容 ▼▲
- 1.Election of the three director nominees named in the Proxy Statement to serve until the annual meeting of stockholders occurring in the fiscal year ending July 31, 2026 (“Fiscal 2026”);
2.Ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for the fiscal year ending July 31, 2023 (“Fiscal 2023”);
3.Approval, on an advisory basis, of the frequency of future stockholder advisory votes on the compensation of our named executive officers;
4.Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company;
5.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2021-11-23 |
股东大会：
将于2022-01-18召开股东大会
会议内容 ▼▲
- 1.Election of the three director nominees named in the Proxy Statement to serve until the annual meeting of stockholders occurring in the fiscal year ending July 31, 2025 (“Fiscal 2025”);
2.Ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for the fiscal year ending July 31, 2022 (“Fiscal 2022”);
3.Approval, on an advisory basis, of the compensation of our named executive officers;
4.Approval, on an advisory basis, of the frequency of future stockholder advisory votes on the compensation of our named executive officers;
5.Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|